Acadia Pharmaceuticals | Dochód Netto



Net Income Zmiana Data
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
ALKERMES USD 367.07M 274.69M 2024-12
Alnylam Pharmaceuticals USD -83763000 27.81M 2024-12
Biogen USD 266.7M 121.8M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Corcept Therapeutics USD 30.75M 16.47M 2024-12
Cytokinetics USD -150020000 10.52M 2024-12
Eisai JPY 23.79B 12.68B 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
Incyte USD 201.21M 94.76M 2024-12
Intra Cellular Therapies USD -16885000 9.44M 2024-12
J&J USD 3.43B 737M 2024-12
Moderna USD -1120000000 1.13B 2024-12
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Pfizer USD 410M 4.06B 2024-12
Prothena USD -57956000 1.04M 2024-12
PTC Therapeutics USD -65886000 40.77M 2024-12
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
Ultragenyx Pharmaceutical USD -133385000 131K 2024-12
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Acadia Pharmaceuticals Dochód Netto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.